JP2023542131A5 - - Google Patents

Info

Publication number
JP2023542131A5
JP2023542131A5 JP2023517283A JP2023517283A JP2023542131A5 JP 2023542131 A5 JP2023542131 A5 JP 2023542131A5 JP 2023517283 A JP2023517283 A JP 2023517283A JP 2023517283 A JP2023517283 A JP 2023517283A JP 2023542131 A5 JP2023542131 A5 JP 2023542131A5
Authority
JP
Japan
Prior art keywords
cedna vector
nucleic acid
acid sequence
itrs
adjacent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023517283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023542131A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/050695 external-priority patent/WO2022061000A1/en
Publication of JP2023542131A publication Critical patent/JP2023542131A/ja
Publication of JP2023542131A5 publication Critical patent/JP2023542131A5/ja
Pending legal-status Critical Current

Links

JP2023517283A 2020-09-16 2021-09-16 フェニルアラニンヒドロキシラーゼ(pah)を発現させるための閉端dnaベクター及びその使用 Pending JP2023542131A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063078954P 2020-09-16 2020-09-16
US63/078,954 2020-09-16
PCT/US2021/050695 WO2022061000A1 (en) 2020-09-16 2021-09-16 Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah)

Publications (2)

Publication Number Publication Date
JP2023542131A JP2023542131A (ja) 2023-10-05
JP2023542131A5 true JP2023542131A5 (cg-RX-API-DMAC7.html) 2024-09-25

Family

ID=80775707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517283A Pending JP2023542131A (ja) 2020-09-16 2021-09-16 フェニルアラニンヒドロキシラーゼ(pah)を発現させるための閉端dnaベクター及びその使用

Country Status (10)

Country Link
US (1) US20240026374A1 (cg-RX-API-DMAC7.html)
EP (1) EP4214309A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023542131A (cg-RX-API-DMAC7.html)
KR (1) KR20230066615A (cg-RX-API-DMAC7.html)
CN (1) CN116507730A (cg-RX-API-DMAC7.html)
AU (1) AU2021345187A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191765A1 (cg-RX-API-DMAC7.html)
IL (1) IL301196A (cg-RX-API-DMAC7.html)
MX (1) MX2023003019A (cg-RX-API-DMAC7.html)
WO (1) WO2022061000A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230079172A (ko) 2020-10-01 2023-06-05 젠자임 코포레이션 간-유도 유전자 대체 요법에 의한 pku의 치료를 위한 인간 pah 발현 카세트
GB202307239D0 (en) * 2023-05-15 2023-06-28 Evox Therapeutics Ltd Gene therapies for Phenylketonuria
IL327036A (en) * 2023-09-19 2026-05-01 Poseida Therapeutics Inc Compositions and methods for combining viral vectors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6879486B2 (ja) * 2015-03-17 2021-06-02 フリーイェ・ユニヴェルシテイト・ブリュッセルVrije Universieit Brussel Fviiiおよびfix用の最適化された肝臓特異的発現系
IL261524B2 (en) * 2016-03-03 2023-10-01 Univ Massachusetts End-capped linear double-stranded DNA for non-viral gene transfer
EP3562494A4 (en) * 2016-12-30 2020-08-19 The Trustees Of The University Of Pennsylvania GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS
MX2020001593A (es) * 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
CA3075168A1 (en) * 2017-09-08 2019-03-14 Generation Bio Co. Modified closed-ended dna (cedna)
JP2021505159A (ja) * 2017-12-06 2021-02-18 ジェネレーション バイオ カンパニー 修飾型閉端dna(cedna)を使用する遺伝子編集
JP2021511047A (ja) * 2018-01-19 2021-05-06 ジェネレーション バイオ カンパニー 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
EP3755803A4 (en) * 2018-02-22 2022-01-19 Generation Bio Co. CONTROLLED EXPRESSION OF TRANSGENES USING DNA (CEDNA) VECTORS
KR20210008501A (ko) * 2018-05-09 2021-01-22 바이오마린 파머수티컬 인크. 페닐케톤뇨증을 치료하는 방법
CN120349985A (zh) * 2018-10-12 2025-07-22 建新公司 通过肝导向基因替代疗法治疗严重pku的改良的人pah的产生
CA3129321A1 (en) * 2019-02-15 2020-08-20 Generation Bio Co. Modulation of rep protein activity in closed-ended dna (cedna) production
US12415002B2 (en) * 2019-03-13 2025-09-16 Generation Bio Co. Non-viral DNA vectors and uses thereof for expressing phenylalanine hydroxylase (PAH) therapeutics
BR112021024124A2 (pt) * 2019-05-31 2022-01-11 American Gene Tech Int Inc Expressão otimizada de fenilalanina hidroxilase

Similar Documents

Publication Publication Date Title
JP2022524434A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2022549380A5 (cg-RX-API-DMAC7.html)
KR102405250B1 (ko) 컬럼-기반 완전히 확장 가능한 rAAV 제조 공정
JP2020532981A5 (cg-RX-API-DMAC7.html)
JP2021087431A5 (cg-RX-API-DMAC7.html)
JP2019116492A5 (cg-RX-API-DMAC7.html)
JP2021003120A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
JP2020533959A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
JP2018522529A5 (cg-RX-API-DMAC7.html)
JP2019503649A5 (cg-RX-API-DMAC7.html)
JP2017509632A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023520763A5 (cg-RX-API-DMAC7.html)
JP2023520764A5 (cg-RX-API-DMAC7.html)
CA3158518A1 (en) Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases
JP2022545121A (ja) Aav5の単離修飾vp1カプシドタンパク質
JP2024159800A (ja) 筋肉発現のためのハイブリッドプロモーター
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2023059858A5 (cg-RX-API-DMAC7.html)
US20160347822A1 (en) Adeno-associated virus mediated delivery of c1ei as a therapy for angioedema
JP2021534766A5 (cg-RX-API-DMAC7.html)
JP2025540074A (ja) 繰り返しエレメントの適切なパッケージングのためのアデノ随伴ウイルスベクター